Eyelash growth in subjects treated with bimatoprost: A multicenter, randomized, double-masked, vehicle-controlled, parallel-group study

Khong, 2006, Madarosis. Surv Ophthalmol, 51, 550, 10.1016/j.survophthal.2006.08.004 Moses, 1970, The eyelids, 1 DeMello, 2007, Facial hair, 109 Shaikh, 2006, Hypertrichosis of the eyelashes from prostaglandin analog use: a blessing or a bother to the patient? [letter], J Ocul Pharmacol Ther, 22, 76, 10.1089/jop.2006.22.76 Woodward, 2008, Prostamides (prostaglandin-ethanolamides) and their pharmacology, Br J Pharmacol, 153, 410, 10.1038/sj.bjp.0707434 Higginbotham, 2002, One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension, Arch Ophthalmol, 120, 1286, 10.1001/archopht.120.10.1286 Whitcup, 2003, A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension, Br J Ophthalmol, 87, 57, 10.1136/bjo.87.1.57 Williams, 2008, Long-term efficacy and safety of bimatoprost for intraocular pressure lowering in glaucoma and ocular hypertension: year 4, Br J Ophthalmol, 92, 1387, 10.1136/bjo.2007.128454 Yoelin S, Wu J, Somogyi C, Beddingfield FCI. Inter-rater and intra-rater reliability of the global eyelash assessment scale for assessment of overall eyelash prominence. Poster presented at: Skin Disease Education Foundation’s 33rd Annual Hawaii Dermatology Seminar; February 7-13, 2009; Maui, HI. Yoelin, 2010, Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth, Dermatol Surg, 36, 638, 10.1111/j.1524-4725.2010.01519.x 2009 Dmitrienko, 2005 Landis, 1977, The measurement of observer agreement for categorical data, Biometrics, 33, 159, 10.2307/2529310 Brandt, 2001, Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial, Ophthalmology, 108, 1023, 10.1016/S0161-6420(01)00584-X Cook, 1995, The number needed to treat: a clinically useful measure of treatment effect, BMJ, 310, 452, 10.1136/bmj.310.6977.452 Tauchi, 2010, Characterization of an in vivo model for the study of eyelash biology and trichomegaly: mouse eyelash morphology, development, growth cycle, and anagen prolongation by bimatoprost, Br J Dermatol, 162, 1186, 10.1111/j.1365-2133.2010.09685.x Johnstone, 2002, Prostaglandin-induced hair growth, Surv Ophthalmol, 47, S185, 10.1016/S0039-6257(02)00307-7 Mansberger, 2000, Eyelash formation secondary to latanoprost treatment in a patient with alopecia, Arch Ophthalmol, 118, 718, 10.1001/archopht.118.5.718 Study of bimatoprost solution in increasing eyelash prominence in African Americans with eyelash hypotrichosis. Available from: http://clinicaltrials.gov/ct2/show/NCT00958035. Accessed September 30, 2009. Safety and efficacy study of bimatoprost to treat hypotrichosis of the eyelashes after application to the eyelid margin. Available from: http://clinicaltrials.gov/ct2/show/study/NCT00907426. Accessed July 26, 2010.